Job title- Associate Scientist, New Ingredient Discovery, S&R (81852) Location– Satigny, Geneva, Switzerland Join our New Ingredients Discovery team as an Associate Scientist, where you will play a key role in accelerating the design and development
About Us Harmattan AI is a next-generation defense prime building autonomous and scalable defense systems. Following the close of a $200M Series B, valuing the company at $1.4 billion, we are expanding our teams and capabilities
ANYbotics is a fast-growing tech company dedicated to shaping the future of mobile robotics across multiple industries. Join our highly talented and motivated team of more than 190 people and work on cutting-edge robot technology. We
Professor of Solid-State Materials The Department of Chemistry and Applied Biosciences (www.chab.ethz.ch) at ETH Zurich and the PSI Center for Neutron and Muon Sciences (CNM, www.psi.ch/en/cnm) at the Paul Scherrer Institute (PSI), Villigen (www.psi.ch) invite applications
Lead Applied Scientist, Search - NLP/GenAI This position is based in either Zug, Switzerland or London, UK. Want to use your experience of building search-led AI solutions to enhance our leading products in the tax, legal
Microcaps is an ETH Zurich spin-off founded in March 2019. Our unique technology allows us to produce highly precise and innovative microcapsules that empower materials to unlock new capabilities; all tailored to various markets from cosmetics
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But they
Job Description RADNEXT 2030 is a Horizon Europe Research Infrastructure Services project that provides coordinated transnational access to radiation effects testing facilities across Europe and beyond. CERN is the project coordinator and also operates two key
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But they
Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryLI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for the Immunology
Department:607000 Regulatory - TTSG Location:St Gallen - Switzerland Be a part of a global team that is inspired to make a difference in the lives of people living with rare disease. At Travere Therapeutics, we recognize
Job Description The Global Hardware Trigger is part of the upgrade to the Trigger and Data Acquisition that ATLAS plans to deploy for the High-Luminosity LHC programme (HL-LHC). It is a custom hardware, real-time data processing
Job Description The objective of the project is to introduce novel selections in the ATLAS trigger to enhance performance in challenging parts of the parameter space, including exotic signatures and rare Standard Model processes, and to improve
Salary Range:CHF129,500.00 - CHF240,500.00 Job Description SummaryJob Title: Associate Director and Senior Principal, AI Methods, AI for Research (AI4R) #LI-Hybrid Location: Basel, Switzerland Relocation Support: This role is based in Basel, Switzerland. Novartis is unable to
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,